IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 114 filers reported holding IGM BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,413,960 | +0.1% | 289,097 | +10.7% | 0.00% | – |
| Q2 2023 | $2,411,328 | -23.6% | 261,249 | +13.7% | 0.00% | – |
| Q1 2023 | $3,157,534 | -59.0% | 229,806 | -49.2% | 0.00% | – |
| Q4 2022 | $7,693,794 | +52.4% | 452,310 | +103.8% | 0.00% | – |
| Q3 2022 | $5,047,000 | +49.5% | 221,950 | +18.5% | 0.00% | – |
| Q2 2022 | $3,376,000 | -26.4% | 187,261 | +9.1% | 0.00% | – |
| Q1 2022 | $4,586,000 | -78.6% | 171,582 | -76.6% | 0.00% | -100.0% |
| Q4 2021 | $21,461,000 | -50.3% | 731,720 | +11.5% | 0.00% | -50.0% |
| Q3 2021 | $43,140,000 | -11.6% | 656,023 | +11.8% | 0.00% | -33.3% |
| Q2 2021 | $48,825,000 | -7.4% | 586,838 | -14.6% | 0.00% | 0.0% |
| Q1 2021 | $52,703,000 | +9.6% | 687,215 | +26.2% | 0.00% | 0.0% |
| Q4 2020 | $48,080,000 | +97.9% | 544,573 | +65.4% | 0.00% | +50.0% |
| Q3 2020 | $24,296,000 | +8.7% | 329,166 | +7.5% | 0.00% | 0.0% |
| Q2 2020 | $22,346,000 | +358.4% | 306,116 | +252.6% | 0.00% | – |
| Q1 2020 | $4,875,000 | +133.3% | 86,813 | +58.5% | 0.00% | – |
| Q4 2019 | $2,090,000 | – | 54,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |